Prosecution Luncheon Patent March 2017

Slides:



Advertisements
Similar presentations
Prosecution Lunch Patent January Extended Missing Parts Pilot Program Requirements –A non-provisional meeting filing-date standards and claiming.
Advertisements

By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
© Kolisch Hartwell 2013 All Rights Reserved, Page 1 America Invents Act (AIA) Implementation in 2012 Peter D. Sabido Intellectual Property Attorney Kolisch.
INTELLECTUAL PROPERTY PROTECTION OFFICE OF PATENT COUNSEL March 16, 2001.
PATENT REFORM University of Rochester KATHRYN DOYLE, Ph.D., J.D. RIVERSIDE LAW, LLP.
Recent Cases on Patentable Subject Matter and Patent Exhaustion Mojdeh Bahar, J.D., M.A. Chief, Cancer Branch Office of Technology Transfer National Institutes.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting October 8, 2002 William F. Smith Administrative Patent Judge Board of Patent Appeals.
UNITED STATES PATENT AND TRADEMARK OFFICE A full transcript of this presentation can be found under the “Notes” Tab. Claim Interpretation: Broadest Reasonable.
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
BIPC.COM STRATEGIC CONSIDERATIONS OF POST ISSUANCE PATENTABILITY REVIEW: THE NEW, OLD, AND NO LONGER Presented By: Todd R. Walters, Esq. B UCHANAN, I NGERSOLL.
Prosecution Group Luncheon Patents August Proposed First-To-File Rules Add definitions in AIA to Rules Declarations for removing references based.
1 1 AIPLA Firm Logo 1 AIPLA Firm Logo American Intellectual Property Law Association CURRENT TRENDS/EFFECTS OF AIA on US Patent Practice at the US Patent.
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
© 2015 Fox Rothschild Inter Partes Review Lessons Learned Scott R. Bialecki Fox Rothschild LLP June 24, 2015.
By Paul J. Lee. Disclaimer The opinions and views expressed in these materials are not necessarily those of DexCom and reflect only the personal views.
AIA Strategies.
A Comparative Analysis of Patent Post-Grant Review Procedures in the U
February 19, Recent Changes and Developments in USPTO Practice Prepared by: Office of Patent Legal Administration (OPLA) Robert J. Spar, DirectorJoni.
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Update on Inter Partes Disputes and the PTAB _____ John B. Pegram Fish & Richardson.
Christopher J. Fildes Fildes & Outland, P.C. Derivation Proceedings and Prior User Rights.
35 U.S.C. 112, Second Paragraph Examination Memorandum Robert Clarke Director, Office of Patent Legal Administration United States Patent and Trademark.
Post-Grant & Inter Partes Review Procedures Presented to AIPPI, Italy February 10, 2012 By Joerg-Uwe Szipl Griffin & Szipl, P.C.
Prosecution Lunch Patents January Reminder: USPTO Fee Changes- Jan. 1, 2014 Issue Fee Decrease- delay paying if you can –Issue Fee: from $1,780.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Overview Validity of patent hinges on novelty, utility, and non-obviousness Utility generally not an issue Pre-suit investigation focuses on infringement,
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
America Invents Act  Date of enactment: 9/16/11  First-to-file provisions effective 18 months after enactment – March 16, 2013  Applications filed on.
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Peter C. Schechter Vice-Chair, AIPPI-US Div. of AIPLA Partner, Osha Liang LLP Post-Issuance Review Proceedings: Update & Trends in IPR & PGR 1 © AIPLA.
1 Advanced Patent Law- Patent Law Institute January 10, 2008 Virginia Rob Clarke, Director, Office of Patent Legal Administration (OPLA) Pitfalls for Practitioners.
Patent Cases MM 450 Issues in New Media Theory Steve Baron March 3, 2009.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
USPTO Guidelines for Determining Obviousness in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc. TC 1600 Biotech/Chem/Pharma.
Prosecution Group Luncheon May, Obviousness—In re Kao (FC 2011) BPAI affirms obviousness rejection: using reference formula, POSA can replace reference’s.
USPTO Guidelines for Determining Obviousness in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc. Kathleen Kahler Fonda Legal.
1 1 AIPLA 1 1 American Intellectual Property Law Association USPTO Post-Grant Procedures and Effective Use of Reissue AIPLA IP Practice in Japan Committee.
DMCA Notices and Patents CasesMM450 February, 2008 And now, for something new, useful and not obvious…
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
PTAB Litigation 2016 Part 2 – The Petition 1. The Petition 2.
Board of Patent Appeals and Interferences May 15, Interference Practice Q&A James T. Moore Administrative Patent Judge
Using the Patent Review Processing System (PRPS) for Post Grant Pilot Applications How to identify relevant information in AIA proceedings at the Patent.
PTAB Litigation 2016 Part 9 – Final Written Decision and Appeal 1.
This Webcast Will Begin Shortly If you have any technical problems with the Webcast or the streaming audio, please contact us via at:
1 TOPIC III - PATENT INVALIDATION PROCEDURES EU-CHINA WORKSHOP ON THE CHINESE PATENT LAW HARBIN, SEPTEMBER 2008 Dr. Gillian Davies.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
PTAB Litigation 2016 Part 3 – The Patent Owner Preliminary Response 1.
PTAB Litigation 2016 Part 11 – Bio/Pharma Issues 1.
ptab game theory: patent owner versus petitioner
PCT-FILING SYSTEM.
Omer/LES International/
Inter Partes Review and District Court
PTAB Litigation 2016 Part 1 – PTAB Basics and Procedure
PATENT OFFICE PROSECUTION
PTAB Litigation 2016 Part 12 – PTAB Popularity and Reasons
Prosecution Group Luncheon
Unless otherwise noted, the content of this course material is licensed under a Creative Commons Attribution 3.0 License.
POST Grant RevieW UPDATES
Processes Which Employ Non-Obvious Products
PTAB Bootcamp: Nuts and Bolts of IPRs, PGRs, and CBMs
Wisdom of the Board Ex parte PTAB Decisions Show Effective Arguments to Overcome an Obviousness Rejection Trent Ostler The content is exclusively the.
Federal Circuit control over PTAB in post-grant proceedings Fordham IP Institute Conference 2018 John Richards.
Patent Trial and Appeal Board Statistics
Update and Practical Considerations
PTAB Litigation 2016 Part 4 – The Institution Decision
The Other 66 Percent: Appeals Before the PTAB
Presentation transcript:

Prosecution Luncheon Patent March 2017

Request for Examination Deadline in the United Kingdom (UK) Docket Items Request for Examination Deadline in the United Kingdom (UK) Previously- 33 months from the earliest priority date. Now- 6 months from publication date (like EPO) When priority based on a PCT application, the earlier PCT publication counts for this 6 month deadline, so you need to request examination upon filing the UK application.

Inter Partes Review (IPR) Appeal Standing Federal Circuit held that a petitioner (Phigenix in this case) lacked standing to appeal an adverse final written decision in an IPR. The petitioner/appellant was "not engaged in any activity that would give rise to a possible infringement suit." Phigenix, Inc. v. ImmunoGen, Inc. 2016-1544 (Fed. Cir. 2017) Is an IPR worth the risk now?

Obviousness- Motivation to Combine In re van Os Examiner PTAB- combination of references would have been “intuitive” (or common sense). “the flexibility afforded by KSR did not extinguish the factfinder’s obligation to provide reasoned analysis. Instead, KSR specifically instructs that when determining whether there would have been a motivation to combine, the ‘analysis should be made explicit.'” (page 4, 2015-1975, Fed. Cir. 2017) http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/15-1975.Opinion.12-28-2016.1.PDF

Obviousness- Motivation to Combine In re van Os Absent some articulated rationale, a finding that a combination of prior art would have been “common sense” or “intuitive” is no different than merely stating the combination “would have been obvious.” Such a conclusory assertion with no explanation is inadequate to support a finding that there would have been a motivation to combine. This type of finding, without more, tracks the ex post reasoning KSR warned of and fails to identify any actual reason why a skilled artisan would have combined the elements in the manner claimed. See 550 U.S. at 418, 421. (Page 5)

Prosecution Luncheon Patent March 2017